
MSD, AZ partner LaNova bought by Sino Biopharm for $951m
LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million.
Newsletters and Deep Dive digital magazine
LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million.
The UK Biobank has completed the world's largest whole body imaging project, compiling more than a billion scans from 100,000 volunteers.
AbbVie has signed another deal in its effort to build an industry-leading position in multispecific antibodies for blood cancers.
Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.
Eli Lilly's Omvoh has been recommended for use in Crohn's disease by NICE, while BeOne's Brukinsa gets the go-ahead for mantle cell lymphoma.
Editor's Picks
Newsletters and Deep Dive
digital magazine